NASP Podcast: A Biologic for CRSwNP – What Specialty Pharmacists Should Know

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dr Andrew Lindsley, US Medical Director at Amgen and Dr Ash Davé, Director, Medical Value and Population Health at Amgen, to discuss a biologic for CRSwNP.

https://youtu.be/uZxtw8Vz6xU

Click here to listen to another NASP Podcast episode with Amgen